Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Pilot Study of a "Large-Eye," Surgically Induced Dry Eye Rabbit Model by Selective Removal of the Harderian, Lacrimal, and Meibomian Glands.

Polans AS, McAnulty JF, Phelps PO, Darjatmoko SR, Burris CK, Albert DM.

Ocul Oncol Pathol. 2017 Dec;4(1):52-56. doi: 10.1159/000475994. Epub 2017 Jul 19.

2.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS.

J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.

3.

Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells.

van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD.

Toxicol Appl Pharmacol. 2015 Nov 1;288(3):453-62. doi: 10.1016/j.taap.2015.08.016. Epub 2015 Sep 1.

4.

The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.

Kanavi MR, Darjatmoko S, Wang S, Azari AA, Farnoodian M, Kenealey JD, van Ginkel PR, Albert DM, Sheibani N, Polans AS.

Molecules. 2014 Oct 30;19(11):17578-603. doi: 10.3390/molecules191117578.

5.

Introducing Krzysztof Palczewski, the 2014 recipient of the Friedenwald award.

Polans AS.

Invest Ophthalmol Vis Sci. 2014 Oct 22;55(10):6649-50. doi: 10.1167/iovs.14-14843. No abstract available.

PMID:
25338685
6.

A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma.

Mahida JP, Antczak C, Decarlo D, Champ KG, Francis JH, Marr B, Polans AS, Albert DM, Abramson DH, Djaballah H.

PLoS One. 2013;8(3):e59156. doi: 10.1371/journal.pone.0059156. Epub 2013 Mar 19.

7.

Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.

Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM.

Int Immunopharmacol. 2011 Nov;11(11):1877-86. doi: 10.1016/j.intimp.2011.07.019. Epub 2011 Aug 18.

8.
9.

Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells.

Kenealey JD, Subramanian L, Van Ginkel PR, Darjatmoko S, Lindstrom MJ, Somoza V, Ghosh SK, Song Z, Hsung RP, Kwon GS, Eliceiri KW, Albert DM, Polans AS.

J Agric Food Chem. 2011 May 11;59(9):4979-86. doi: 10.1021/jf104901g. Epub 2011 Apr 12.

10.

The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.

Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM.

Cancer Immunol Immunother. 2011 May;60(5):731-8. doi: 10.1007/s00262-011-0971-0. Epub 2011 Feb 22.

11.

Resveratrol: challenges in translation to the clinic--a critical discussion.

Subramanian L, Youssef S, Bhattacharya S, Kenealey J, Polans AS, van Ginkel PR.

Clin Cancer Res. 2010 Dec 15;16(24):5942-8. doi: 10.1158/1078-0432.CCR-10-1486. Epub 2010 Nov 2. Review.

12.

Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction.

van Ginkel PR, Darjatmoko SR, Sareen D, Subramanian L, Bhattacharya S, Lindstrom MJ, Albert DM, Polans AS.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1299-306. doi: 10.1167/iovs.07-1233.

13.

Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer.

Sareen D, Darjatmoko SR, Albert DM, Polans AS.

Mol Pharmacol. 2007 Dec;72(6):1466-75. Epub 2007 Sep 11.

PMID:
17848600
14.

Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria.

van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, Lindstrom MJ, Kulkarni A, Albert DM, Polans AS.

Clin Cancer Res. 2007 Sep 1;13(17):5162-9.

15.

Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.

Sareen D, van Ginkel PR, Takach JC, Mohiuddin A, Darjatmoko SR, Albert DM, Polans AS.

Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3708-16.

PMID:
16936077
16.

Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma.

Subramanian L, Crabb JW, Cox J, Durussel I, Walker TM, van Ginkel PR, Bhattacharya S, Dellaria JM, Palczewski K, Polans AS.

Biochemistry. 2004 Sep 7;43(35):11175-86.

17.

Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins.

Subramanian L, Polans AS.

Biochem Biophys Res Commun. 2004 Oct 1;322(4):1153-65. Review.

PMID:
15336963
18.

Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.

van Ginkel PR, Gee RL, Shearer RL, Subramanian L, Walker TM, Albert DM, Meisner LF, Varnum BC, Polans AS.

Cancer Res. 2004 Jan 1;64(1):128-34.

19.

Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.

Walker TM, Van Ginkel PR, Gee RL, Ahmadi H, Subramanian L, Ksander BR, Meisner LF, Albert DM, Polans AS.

Arch Ophthalmol. 2002 Dec;120(12):1719-25.

PMID:
12470148
20.

An improved tripod amphiphile for membrane protein solubilization.

Yu SM, McQuade DT, Quinn MA, Hackenberger CP, Krebs MP, Polans AS, Gellman SH.

Protein Sci. 2000 Dec;9(12):2518-27.

21.

Calcium-binding proteins and their assessment in ocular diseases.

Polans AS, Gee RL, Walker TM, van Ginkel PR.

Methods Enzymol. 2000;316:103-21. No abstract available.

PMID:
10800671
22.

Rigid Amphiphiles for Membrane Protein Manipulation.

McQuade DT, Quinn MA, Yu SM, Polans AS, Krebs MP, Gellman SH.

Angew Chem Int Ed Engl. 2000 Feb;39(4):758-761. No abstract available.

PMID:
10760860
23.

Ca(2+)-binding proteins in the retina: structure, function, and the etiology of human visual diseases.

Palczewski K, Polans AS, Baehr W, Ames JB.

Bioessays. 2000 Apr;22(4):337-50. Review.

PMID:
10723031
24.

The identification and differential expression of calcium-binding proteins associated with ocular melanoma.

Van Ginkel PR, Gee RL, Walker TM, Hu DN, Heizmann CW, Polans AS.

Biochim Biophys Acta. 1998 Dec 10;1448(2):290-7.

25.

Calcium binding to recoverin: implications for secondary structure and membrane association.

Johnson WC Jr, Palczewski K, Gorczyca WA, Riazance-Lawrence JH, Witkowska D, Polans AS.

Biochim Biophys Acta. 1997 Oct 17;1342(2):164-74.

PMID:
9392525
26.

Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.

Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G.

Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9176-80.

27.

Guanylyl cyclase activating protein. A calcium-sensitive regulator of phototransduction.

Gorczyca WA, Polans AS, Surgucheva IG, Subbaraya I, Baehr W, Palczewski K.

J Biol Chem. 1995 Sep 15;270(37):22029-36.

28.

Differential distribution of six calcium-binding proteins in the rat olfactory epithelium during postnatal development and adulthood.

Bastianelli E, Polans AS, Hidaka H, Pochet R.

J Comp Neurol. 1995 Apr 10;354(3):395-409.

PMID:
7541806
29.

Calbindin D-28K immunoreactivity of human cone cells varies with retinal position.

Haley TL, Pochet R, Baizer L, Burton MD, Crabb JW, Parmentier M, Polans AS.

Vis Neurosci. 1995 Mar-Apr;12(2):301-7.

PMID:
7786851
30.

Localization of three genes expressed in retina on mouse chromosome 11.

Kozak CA, Danciger M, Bowes C, Adamson MC, Palczewski K, Polans AS, Farber DB.

Mamm Genome. 1995 Feb;6(2):142-4. No abstract available.

PMID:
7767000
31.

Purification and primary structure of Capl, an S-100-related calcium-binding protein isolated from bovine retina.

Polans AS, Palczewski K, Asson-Batres MA, Ohguro H, Witkowska D, Haley TL, Baizer L, Crabb JW.

J Biol Chem. 1994 Feb 25;269(8):6233-40.

32.

Identification of the N-terminal region in rhodopsin kinase involved in its interaction with rhodopsin.

Palczewski K, Buczyłko J, Lebioda L, Crabb JW, Polans AS.

J Biol Chem. 1993 Mar 15;268(8):6004-13.

33.

The effect of recoverin-like calcium-binding proteins on the photoresponse of retinal rods.

Gray-Keller MP, Polans AS, Palczewski K, Detwiler PB.

Neuron. 1993 Mar;10(3):523-31.

PMID:
8461139
34.

Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy.

Polans AS, Burton MD, Haley TL, Crabb JW, Palczewski K.

Invest Ophthalmol Vis Sci. 1993 Jan;34(1):81-90.

PMID:
8425844
35.

Distribution of 5-HT1 binding sites in cat spinal cord.

Pubols LM, Bernau NA, Kane LA, Dawson SD, Burleigh AL, Polans AS.

Neurosci Lett. 1992 Aug 17;142(2):111-4.

PMID:
1454202
36.

Mechanism of rhodopsin kinase activation.

Palczewski K, Buczyłko J, Kaplan MW, Polans AS, Crabb JW.

J Biol Chem. 1991 Jul 15;266(20):12949-55.

37.
38.
39.

Sialoglycoproteins of the frog rod outer segment plasma membrane.

Polans AS, Burton MD.

Invest Ophthalmol Vis Sci. 1988 Oct;29(10):1523-32.

PMID:
3262600
41.

Muscarinic cholinergic receptors in the retina of the larval tiger salamander.

Polans AS, Hutchins JB, Werblin FS.

Brain Res. 1985 Aug 12;340(2):355-62.

PMID:
4027656
42.

Localization of cholinesterase activity in the outer plexiform layer of the larval tiger salamander retina.

Hutchins JB, Polans AS, Werblin FS.

Brain Res. 1984 Feb 6;292(2):303-15.

PMID:
6140990
43.
44.

Supplemental Content

Loading ...
Support Center